Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | STE | ABT |
|---|---|---|
| Price | $209.21 | $97.53 |
| Change today | ▼ 0.38% | ▼ 1.32% |
| Market cap | $20.40B | $168.76B |
| Return, 3 months | -1.2% | +6.6% |
| Return, year to date | -16.8% | -20.7% |
| Return, 1 year | -12.3% | -25.2% |
| P/E (TTM) | 25.6 | 31.6 |
| P/B | 2.8 | 3.3 |
| P/E percentile vs own 5y | 11th | 69th |
| Dividend yield | 1.20% | 2.50% |
| Revenue growth (YoY, latest qtr) | +7.3% | +13.0% |
| Net profit growth (YoY) | +12.9% | -47.8% |
| Gross margin | 44.4% | 56.6% |
| Operating margin | 18.9% | 15.8% |
| Net margin | 13.3% | 11.6% |
| Return on equity | 11.4% | 10.7% |
| Analyst target vs. price | +29.7% | +27.5% |
| Analyst buy share | 75% | 100% |
| RSI (14) | 38 | 30 |
| 30-day volatility | 16.8% | 20.3% |
| Max drawdown, 1 year | -25.4% | -38.6% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
